Volume 27, Issue 6 (1-2025)
J Arak Uni Med Sci 2025, 27(6): 310-318 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sarmadian H, Zarinfar N, Bahrami M, Arjmandzadegan M M, Sarmadian R, Zarinfar Y. Frequency of Different Symptoms in Patients with Omicron 2022 in Arak. J Arak Uni Med Sci 2025; 27 (6) :310-318
URL: http://jams.arakmu.ac.ir/article-1-7721-en.html
URL: http://jams.arakmu.ac.ir/article-1-7721-en.html
Hosein Sarmadian1 
, Nader Zarinfar1 , Masoud Bahrami2 , Mohammad Matin Arjmandzadegan3 , Roham Sarmadian3 , Yasamin Zarinfar3
, Nader Zarinfar1 , Masoud Bahrami2 , Mohammad Matin Arjmandzadegan3 , Roham Sarmadian3 , Yasamin Zarinfar3
1- Department of Infectious Disease, Infectious Diseases Research Center, Arak University of Medical Sciences, Arak, Iran
2- Department of Infectious Disease, Infectious Diseases Research Center, Arak University of Medical Sciences, Arak, Iran ,masoud.bahrami87@gmail.com
3- Students Research Committee, Arak University of medical sciences, Arak, Iran
2- Department of Infectious Disease, Infectious Diseases Research Center, Arak University of Medical Sciences, Arak, Iran ,
3- Students Research Committee, Arak University of medical sciences, Arak, Iran
Abstract: (615 Views)
Introduction: The Symptoms of Omicron are still unknown. Primary data show that the Omicron symptoms are mainly related to the respiratory system, including runny nose, sore throat, headache, fatigue, and sneezing. Based on the need for more evidence about Omicron symptoms, this study was conducted to investigate the symptoms of this COVID serotype.
Methods: This descriptive-analytical cross-sectional study was performed for 6 months in Arak city on 160 definitively diagnosed patients with Omicron. For all patients who entered the study, the information evaluation checklist, including demographics and symptoms (24 symptoms), was completed. Disease diagnosis was done by PCR.
Results: The disease of 55% of people was mild, 35% moderate, and 10% severe. Fifty-one people (31.9%) mentioned a history of previous infection with COVID-19. Pulmonary involvement, the type of drug used, and anxiety at the time of infection were related to the severity of the disease (P < 0.05). The five most common symptoms of Omicron (%) were sore throat (86.3), cough (82.5), weakness and lethargy (76.3), headache (72.5) and dry mouth (62.5). There was also a relationship between old age with dry mouth and headache, underlying disease with sneezing, anxiety during illness with joint pain and chest pain, and smoking with abdominal pain (P < 0.05).
Conclusions: The most common symptoms included sore throat, cough, weakness and lethargy, headache, and musculoskeletal pain. However, reduced smell and taste, night sweats, fever, and joint pain, common in the previous serotypes, were among the less frequent symptoms of Omicron.
Methods: This descriptive-analytical cross-sectional study was performed for 6 months in Arak city on 160 definitively diagnosed patients with Omicron. For all patients who entered the study, the information evaluation checklist, including demographics and symptoms (24 symptoms), was completed. Disease diagnosis was done by PCR.
Results: The disease of 55% of people was mild, 35% moderate, and 10% severe. Fifty-one people (31.9%) mentioned a history of previous infection with COVID-19. Pulmonary involvement, the type of drug used, and anxiety at the time of infection were related to the severity of the disease (P < 0.05). The five most common symptoms of Omicron (%) were sore throat (86.3), cough (82.5), weakness and lethargy (76.3), headache (72.5) and dry mouth (62.5). There was also a relationship between old age with dry mouth and headache, underlying disease with sneezing, anxiety during illness with joint pain and chest pain, and smoking with abdominal pain (P < 0.05).
Conclusions: The most common symptoms included sore throat, cough, weakness and lethargy, headache, and musculoskeletal pain. However, reduced smell and taste, night sweats, fever, and joint pain, common in the previous serotypes, were among the less frequent symptoms of Omicron.
References
1. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603(7902):679-86. pmid: 35042229 doi: 10.1038/s41586-022-04411-y
2. Chen J, Wang R, Gilby NB, Wei GW. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model. 2022;62(2):412-22. pmid: 34989238 doi: 10.1021/acs.jcim.1c01451
3. Avraham D, Herman A, Shaham G, Shklyar A, Sulim E, Oulianski M. Lab results of COVID-19 patients: Omicron vs delta variants. World J Virol. 2024;13(2):90761. pmid: 38984078 doi: 10.5501/wjv.v13.i2.90761
4. Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. S ymptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618-24. pmid: 35397851 doi: 10.1016/S0140-6736(22)00327-0
5. Haghnegahdar A, Bronoosh P, Aidenlou S. Assessment of mothers'knowledge of sequence and time of deciduous and permanent teeth eruption in children [in Persian]. Sadra Med Sci J. 2013;2(1):43-54.
6. McDonald RE, Avery DR, Dean JA. Dentistry for the child and adolescent. St. Louis: Elsevier; 2004.
7. Espenhain L, Funk T, Overvad M, Edslev SM, Fonager J, Ingham AC, et al. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Euro Surveill. 2021;26(50):2101146. pmid: 34915977 doi: 10.2807/1560-7917.ES.2021.26.50.2101146
8. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. pmid: 32091533 doi: 10.1001/jama.2020.2648
9. Lai C-C, Ko W-C, Lee P-I, Jean S-S, Hsueh P-R. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56(2):106024. pmid: 32450197 doi: 10.1016/j.ijantimicag.2020.106024
10. Iacobucci G. COVID-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ (Clinical research ed). 2021;375:n3103. pmid: 34916215 doi: 10.1136/bmj.n3103
11. Pourriyahi H, Hajizadeh N, Khosravi M, Pourriahi H, Soleimani S, Hosseini NS, et al. New variants of COVID-19 (XBB.1.5 and XBB.1.16, the "Arcturus"): A review of highly questioned concerns, a brief comparison between different peaks in the COVID-19 pandemic, with a focused systematic review on expert recommendations for prevention, vaccination, and treatment measures in the general population and at-risk groups. Immun Inflamm Dis. 2024;12(6):e1323. pmid: 38938013 doi:.1002/iid3.1323
12. Tureček P, Kleisner K. Symptomic Mimicry Between SARS-CoV-2 and the Common Cold Complex. Biosemiotics. 2022;15(1):61-6. pmid: 35035606 doi: 10.1007/s12304-021-09472-6
13. Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Møller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022;22(7):967-76. pmid: 35468331 doi: 10.1016/S1473-3099(22)00154-2
14. Kim MK, Lee B, Choi YY, Um J, Lee KS, Sung HK, et al. Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea. J Korean Med Sci. 2022;37(3):e31. pmid: 35040299 doi: 10.3346/jkms.2022.37.e31
15. Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618-24. pmid: 35397851 doi: 10.1016/S0140-6736(22)00327-0
16. Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437-46. pmid: 35065011 doi: 10.1016/S0140-6736(22)00017-4
17. Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613-28. pmid: 33011887 doi: 10.1007/s10735-020-09915-3
18. Ledford H. How severe are Omicron infections? Nature. 2021;600(7890):577-8. pmid: 34934198 doi: 10.1038/d41586-021-03794-8
19. Hui KPY, Ho JCW, Cheung MC, Ng KC, Ching RHH, Lai KL, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715-20. pmid: 35104836 doi: 10.1038/s41586-022-04479-6
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
